{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:52Z","timestamp":1791474712885,"version":"4.3.4"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Time toxicity, defined as the time patients spend receiving cancer treatment and interacting with health care systems, is an emerging treatment-related burden. Existing studies typically quantify time toxicity using health care contact days, which may inadequately capture patient burden because encounters of different durations are weighted equally.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To develop and internally validate the Multinational Association of Supportive Care in Cancer (MASCC) Time Intensity and Measurement of Encounters (TIME) tool, a standardized medical record abstraction instrument for measuring documented health care encounter time.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This multiphase mixed-methods prognostic study, including tool development, was conducted from March to May 2026, through a 3-round international consensus process involving 16 oncology trialists from 9 countries and internal validation using electronic medical records from a cohort of patients with prostate cancer treated at a tertiary cancer center in Toronto, Ontario, Canada. Validation compared standardized abstraction using the MASCC TIME tool with prior unstructured medical record abstraction across 367 health care encounters.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Content validity, extraction accuracy compared with investigator consensus review, interrater reliability assessed using the Gwet agreement coefficient 1 (AC1) and percentage agreement, and abstraction feasibility.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Sixteen oncology trialists participated in tool development. The final tool included 8 variables: encounter start date, start time, end date, end time, purpose, planned or unplanned status, mode of contact, and primary clinician. All variables achieved a content validity ratio of 1.0. Accuracy of medical record extraction increased from 31% (95% CI, 28%-35%) to 90% (95% CI, 87%-93%) without the tool to 66% (95% CI, 62%-69%) to 99% (95% CI, 99%-100%) with the tool, with absolute differences of 2 percentage points (95% CI, \u22121 to 5 percentage points) to 35 percentage points (95% CI, 30 to 40 percentage points); 7 of 8 variables demonstrated statistically significant increases with the tool. Percentage agreement between abstractors increased from 31% to 82% without the tool to 42% to 99% with the tool, while the Gwet AC1 increased from \u22120.24 to 0.87 without the tool to 0.14 to 0.99 with the tool. Mean abstraction time decreased from 10 to 5 minutes per encounter.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this prognostic study of the MASCC TIME tool, it was found to be associated with excellent content validity, improved accuracy, high interrater reliability, and acceptable feasibility for standardized measurement of documented health care encounter time. Standardized assessment of time toxicity may improve comparability across oncology studies and support more rigorous evaluation of health care\u2013related burden in cancer research.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.38034","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:51Z","timestamp":1791471651000},"page":"e2638034","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of a Tool to Measure Documented Health Care Encounter Time"],"prefix":"10.1001","volume":"9","author":[{"given":"Ronald","family":"Chow","sequence":"first","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bayrakdarian","sequence":"additional","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Gojsevic","sequence":"additional","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"MacMillan","sequence":"additional","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Balboni","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute\/Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Bowen","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Biomedical Science, Adelaide University, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Chan","sequence":"additional","affiliation":[{"name":"Caring Futures Institute, College of Health and Enablement, Flinders University, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Gupta","sequence":"additional","affiliation":[{"name":"City of Hope Cancer Center Phoenix, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas H.","family":"Hart","sequence":"additional","affiliation":[{"name":"Caring Futures Institute, College of Health and Enablement, Flinders University, Adelaide, South Australia, Australia"},{"name":"Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[{"name":"Mount Vernon Cancer Centre, Northwood, United Kingdom"},{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hui","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Iihara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gifu University Hospital, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jefford","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research in Cancer, Australia Cancer Survivorship Centre, and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing Fung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Riechelmann","sequence":"additional","affiliation":[{"name":"Clinical Oncology Department, AC Camargo Cancer Center, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina H.","family":"Ruhlmann","sequence":"additional","affiliation":[{"name":"Department of Oncology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[{"name":"New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C. Y.","family":"Wong","sequence":"additional","affiliation":[{"name":"New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Chung","sequence":"additional","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia C.","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Forensic Sciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leigh","sequence":"additional","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MASCC Emerging Toxicities Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"3","key":"zoi261025r1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"zoi261025r2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5306\/wjco.v12.i3.150","article-title":"Systemic adverse effects and toxicities associated with immunotherapy: a review.","volume":"12","author":"Kichloo","year":"2021","journal-title":"World J Clin Oncol"},{"issue":"3","key":"zoi261025r3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"zoi261025r4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1200\/JCO.2017.74.7907","article-title":"The toxicity of time.","volume":"36","author":"Daily","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15","key":"zoi261025r5","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","article-title":"The time toxicity of cancer treatment.","volume":"40","author":"Gupta","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi261025r6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1200\/OP.23.00590","article-title":"Health care contact days among older cancer survivors.","volume":"20","author":"Gupta","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"zoi261025r7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1200\/OP.2024.20.10_suppl.233","article-title":"Counting the days: exploring healthcare contact days during episodes of cancer care.","volume":"20","author":"Liu","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"zoi261025r8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/spcare-2025-006038","article-title":"Time toxicity of patients with cancer enrolled in clinical trials: a systematic review and meta-analysis.","volume":"16","author":"Chow","year":"2026","journal-title":"BMJ Support Palliat Care"},{"key":"zoi261025r9","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2026-006361","article-title":"Time toxicity in patients receiving brachytherapy and hormonal therapy for recurrent prostate cancer: a cohort study.","author":"Chow","journal-title":"BMJ Support Palliat Care"},{"issue":"10","key":"zoi261025r10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00520-025-09904-w","article-title":"The weight of time: experience of time toxicity among advanced cancer patients and their family caregivers\u2014a qualitative study.","volume":"33","author":"Jing","year":"2025","journal-title":"Support Care Cancer"},{"issue":"4","key":"zoi261025r11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1744-6570.1975.tb01393.x","article-title":"A quantitative approach to content validity.","volume":"28","author":"Lawshe","year":"1975","journal-title":"Pers Psychol"},{"issue":"8","key":"zoi261025r13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"issue":"1","key":"zoi261025r14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jclinepi.2010.03.002","article-title":"Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed.","volume":"64","author":"Kottner","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi261025r15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2288-13-61","article-title":"A comparison of Cohen\u2019s kappa and Gwet\u2019s AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples.","volume":"13","author":"Wongpakaran","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"zoi261025r16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic.","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"12","key":"zoi261025r17","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjon.2024.100610","article-title":"Time toxicity in cancer care: a concept analysis using Walker and Avant\u2019s method.","volume":"11","author":"Nwozichi","year":"2024","journal-title":"Asia Pac J Oncol Nurs"},{"key":"zoi261025r12","volume-title":"Content Validity Ratio","author":"Rutherford-Hemming","year":"2018"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854970\/chow_2026_oi_261025_1790865020.80073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:53Z","timestamp":1791471653000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.38034","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}